Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycoplasma hyopneumoniae P97 adhesin (P97) is a critical surface-exposed protein of the wall-less bacterium Mycoplasma hyopneumoniae, the primary causative agent of enzootic pneumonia in swine. This protein functions as a major adhesin, mediating the attachment of the pathogen to the ciliated respiratory epithelium of the host, which is a prerequisite for colonization and disease progression (Minion et al., 2000). As a key immunological target, P97 is widely utilized in the development of both whole-cell bacterin vaccines and recombinant subunit vaccines aimed at inducing protective mucosal immunity (Simionatto et al., 2013). Interaction with these vaccines triggers the production of neutralizing antibodies that block the protein's repeat regions, thereby preventing bacterial adherence and reducing the severity of lung lesions. Additionally, P97 serves as a significant diagnostic marker for monitoring herd exposure and vaccine efficacy through serological assays. Despite its importance, the high degree of genetic variability in the P97 gene across different strains presents a challenge for the design of universally effective vaccines (Hsu & Minion, 1998).
Vaccines targeting the P97 adhesin induce the production of specific mucosal and systemic antibodies (IgA and IgG) that bind to the protein's R1 and R2 repeat regions, sterically hindering the bacterium's ability to adhere to the host's ciliated respiratory epithelium and preventing colonization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycoplasma hyopneumoniae P97 adhesin (P97) (P97).